Evaxion Biotech is an AI-immunology platform company decoding the immune system to discover and develop immunotherapies for cancer and other diseases.
Location: Denmark, Capital Region of Denmark, Copenhagen
Employees: 51-200
Total raised: $67.6M
Founded date: 2008
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.06.2022 | - | $40M | - |
| 05.11.2021 | - | $27.6M | - |
Mentions in press and media 23
| Date | Title | Description | Source |
| 05.06.2023 | Evaxion’s AI Technology Identifies Cancer Vaccine Targets As... | The clinical trial of the personalized cancer vaccine EVX-01 met its primary endpoints of safety and... | aithority.... |
| 15.04.2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Auto... | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates wi... | aithority.... |
| 14.04.2023 | Evaxion And Pennsylvania State University Publish Preclinica... | Evaxion Biotech A/S, a clinical-stage biotechnology company specializing in AI-powered immunotherapi... | aithority.... |
| 23.03.2023 | Evaxion Presents A New Source Of AI-derived Immunotherapeuti... | Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapy ... | aithority.... |
| 30.06.2022 | Evaxion Biotech Announces Gonorrhea as Second Bacterial Prod... | COPENHAGEN, Denmark, June 30, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”... | globenewsw... |
| 23.06.2022 | Evaxion Biotech Expands Its EVX-03 DNA Vaccine Program Into ... | COPENHAGEN, Denmark, June 23, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”... | globenewsw... |
| 07.06.2022 | Evaxion Biotech Secures Equity Financing of up to $40 Millio... | COPENHAGEN, Denmark, June 07, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”... | globenewsw... |
| 10.11.2021 | Evaxion Biotech Announces Closing of $27.6 Million Follow-on... | COPENHAGEN, Denmark, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”... | marketscre... |
| 09.11.2021 | Evaxion Biotech Announces Closing of $27.6 Million Follow-on... | COPENHAGEN, Denmark, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”... | globenewsw... |
| 09.11.2021 | Evaxion Biotech Announces Q3 2021 Financial Results and Prov... | Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update ● Expect to close o... | marketscre... |
Show more